ReviewImmunology and allergy clinics of North America2009
Mechanism of eosinophilic esophagitis.
Review in Immunology and allergy clinics of North America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 50 citations in OpenAlex.
- Eosinophilic esophagitis in children: A multicenter study evaluating current practices in Mexico.The journal of allergy and clinical immunology. Global · 2025Article
- Stem cell factor inhibition reduces Th2 inflammation and cellular infiltration in a mouse model of eosinophilic esophagitis.Mucosal immunology · 2023Article
- Allergen-induced NLRP3/caspase1/IL-18 signaling initiate eosinophilic esophagitis and respective inhibitors protect disease pathogenesis.Communications biology · 2023Article
- An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.Medicina (Kaunas, Lithuania) · 2022Review
- Dysmotility in Eosinophilic Esophagitis.Frontiers in pediatrics · 2022Review
- Significance of Interleukin (IL)-15 in IgE associated eosinophilic Esophagitis (EoE).International journal of basic and clinical immunology · 2019Article
- Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.Clinical reviews in allergy & immunology · 2018Review
- Food allergy and eosinophilic esophagitis in India: Lack of diagnosis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2016Article
- Role of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic Esophagitis.Gastrointestinal endoscopy clinics of North America · 2016Review
- Allergen-induced interleukin-18 promotes experimental eosinophilic oesophagitis in mice.Immunology and cell biology · 2015Article
- Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis.Clinical immunology (Orlando, Fla.) · 2015Article
- Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.PloS one · 2015Article
- Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.Gastroenterology clinics of North America · 2014Review
- Emerging therapeutic options for eosinophilic esophagitis.Gastroenterology & hepatology · 2014Article
- Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis.Clinical & translational immunology · 2014Article
- The role of allergy evaluation in children with eosinophilic esophagitis.Journal of gastroenterology · 2013Article
- HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells.American journal of physiology. Gastrointestinal and liver physiology · 2012Article
- Esophageal functional impairments in experimental eosinophilic esophagitis.American journal of physiology. Gastrointestinal and liver physiology · 2012Article
- Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis.American journal of physiology. Gastrointestinal and liver physiology · 2012Article
- Management of pediatric eosinophilic esophagitis: an update.Paediatric drugs · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Eosinophilic esophagitis (EoE) is a newly recognized disease and is an emerging entity throughout developing and developed countries, including the United States. Therefore, understanding the causes, natural history, diagnosis, and management is important for future therapeutic interventions. The pathogenesis of EoE is still not clear, but a growing body of evidence has established that this condition represents a T-cell-mediated immune response involving several proinflammatory mediators and chemoattractants known to regulate eosinophilic accumulation in the esophagus, such as IL-4, IL-5, IL-3 and eotaxin-1, -2, and -3. Determining the mechanism or mechanisms through which human esophageal-derived factors ultimately induce the functional abnormalities observed, and to which antigens patients who have EoE are sensitized that lead to the manifestation of symptoms, is of significant interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.